- Outcomes of long-term maintenance infliximab therapy in adult patients with moderate to severe Crohn's disease from March 2003 to December 2010: A single centre experience2012 | Matematicko-fyzikální fakulta
- Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study2017 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy2017 | 1. lékařská fakulta
- Adalimumab biosimilars in the therapy of Crohn's disease and ulcerative colitis: Prospective multicentric clinical monitoring2022 | 1. lékařská fakulta, Lékařská fakulta v Plzni, 2. lékařská fakulta, 3. lékařská fakulta
- Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis2016 | 1. lékařská fakulta, Lékařská fakulta v Plzni, 2. lékařská fakulta, 3. lékařská fakulta
- Vedolizumab as induction and maintenance therapy for Crohn's disease2013 | 1. lékařská fakulta